WallStreetZenWallStreetZen

NASDAQ: SVRA
Savara Inc Stock

$3.78+0.00 (+0%)
Updated Sep 29, 2023
SVRA Price
$3.78
Fair Value Price
$4.00
Market Cap
$510.96M
52 Week Low
$1.08
52 Week High
$4.21
P/E
-13.5x
P/B
5.83x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$42.69M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.37
Operating Cash Flow
-$39M
Beta
0.77
Next Earnings
Nov 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

SVRA Overview

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SVRA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SVRA ($3.78) is undervalued by 5.56% relative to our estimate of its Fair Value price of $4.00 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SVRA ($3.78) is not significantly undervalued (5.56%) relative to our estimate of its Fair Value price of $4.00 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SVRA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SVRA due diligence checks available for Premium users.

Be the first to know about important SVRA news, forecast changes, insider trades & much more!

SVRA News

Valuation

SVRA fair value

Fair Value of SVRA stock based on Discounted Cash Flow (DCF)
Price
$3.78
Fair Value
$4.00
Undervalued by
5.56%
SVRA ($3.78) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SVRA ($3.78) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SVRA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SVRA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-13.5x
Industry
13.67x
Market
12.37x

SVRA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.83x
Industry
5.09x
SVRA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SVRA's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.4M
Profit Margin
0%
SVRA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$119.8M
Liabilities
$32.1M
Debt to equity
0.37
SVRA's short-term assets ($107.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SVRA's short-term assets ($107.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SVRA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SVRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.3M
Investing
-$1.0M
Financing
$104.0k
SVRA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SVRA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SVRA$510.96M0.00%-13.50x5.83x
OLMA$510.70M-4.85%-5.12x3.16x
RPTX$508.50M-1.55%-201.33x2.07x
GHRS$522.81M-4.47%-14.67x2.24x
TRDA$525.69M-2.35%-6.15x2.54x

Savara Stock FAQ

What is Savara's quote symbol?

(NASDAQ: SVRA) Savara trades on the NASDAQ under the ticker symbol SVRA. Savara stock quotes can also be displayed as NASDAQ: SVRA.

If you're new to stock investing, here's how to buy Savara stock.

What is the 52 week high and low for Savara (NASDAQ: SVRA)?

(NASDAQ: SVRA) Savara's 52-week high was $4.21, and its 52-week low was $1.08. It is currently -10.21% from its 52-week high and 250% from its 52-week low.

How much is Savara stock worth today?

(NASDAQ: SVRA) Savara currently has 135,173,441 outstanding shares. With Savara stock trading at $3.78 per share, the total value of Savara stock (market capitalization) is $510.96M.

Savara stock was originally listed at a price of $8.76 in Apr 28, 2017. If you had invested in Savara stock at $8.76, your return over the last 6 years would have been -56.85%, for an annualized return of -13.07% (not including any dividends or dividend reinvestments).

How much is Savara's stock price per share?

(NASDAQ: SVRA) Savara stock price per share is $3.78 today (as of Sep 29, 2023).

What is Savara's Market Cap?

(NASDAQ: SVRA) Savara's market cap is $510.96M, as of Sep 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Savara's market cap is calculated by multiplying SVRA's current stock price of $3.78 by SVRA's total outstanding shares of 135,173,441.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.